Hawaii and 41 other states won a $35 million drug settlement with Pfizer Inc.

The Aloha State will receive more than $448,000 as part of the settlement, which involved unlawful promotion of an immunosuppressive drug used as a prophylactic for organ rejection after kidney transplant surgery, according to a news release issued Wednesday by the state Office of Consumer Protection.

Wyeth Pharmaceuticals Inc., owned by Pfizer, allegedly violated Hawaii’s consumer protection laws by misrepresenting the uses and benefits of Rapamune, an immunosuppressive drug currently approved by the U.S. Food and Drug Administration.The states’ attorneys general said Wednesday that Wyeth, which Pfizer bought in 2009, trained sales representatives to encourage doctors to prescribe Rapamune for uses other than preventing rejection of transplanted kidneys.